--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "MGH Nephrology Guide" developer_entity: "Unbound Medicine, Inc." bundle_id: "com.unboundmedicine.MGHNephrologyGuide" app_store_id: "1346849427" google_play_id: "com.unbound.android.ubneph" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-03-09" report_date: "2026-08-01" last_verified: "2026-08-01T00:00:00.000Z" report_version: "1.6" total_reviews: 44 overall_rating: 4.8 sentiment: "Upset" sentiment_score: 10 confidence: "medium" confidence_score: 0.55 top_complaint_theme: "Information depth on specific topics feels insufficient for users seeking comprehensive educational or reference material" review_sample_size: 1 total_review_count: 1 analyzed_review_count: 1 data_age_days: 67 intelligence_version: 3 tags: ["medical", "subscription", "upset sentiment", "mobile app", "app review", "app analysis", "nephrology", "fellows,", "attendings,"] canonical_url: "https://marlvel.ai/apps/mgh-nephrology-guide" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # MGH Nephrology Guide Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.8 · Sentiment Upset - **Recent focus**: Information depth on specific topics feels insufficient for users seeking comprehensive educational or reference material (top complaint) > **TL;DR:** MGH Nephrology Guide is a medical app by Unbound Medicine, Inc., rated 4.8/5 by 44 users, with Upset user sentiment (10/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** MGH Nephrology Guide faces Upset user sentiment (4.8/5 from 44 reviews), with users reporting information depth on specific topics feels insufficient for users seeking comprehensive educational or reference material as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.8/5 (44 reviews) | | **User Mood** | Upset | | **Category** | Medical | | **Developer** | Unbound Medicine, Inc. | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.55/1.0) | | **Data Age** | 67d | ## Metadata & Market Performance - **Publisher:** Unbound Medicine, Inc. - **Category:** Medical - **Target Audience:** Nephrology fellows, attendings, dialysis nurses, residents, and primary care physicians. - **Platforms:** iOS & Android - **Version Reviewed:** 1.6 - **Report Date:** 2026-08-01 - **Signal Count:** 1 review analyzed - **Confidence:** Medium (0.55/1.0) - **App Store ID (iOS):** 1346849427 - **Bundle ID:** com.unboundmedicine.MGHNephrologyGuide - **Google Play ID:** com.unbound.android.ubneph - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-08-01 ## Executive Snapshot **What it is:** MGH Nephrology Guide is a clinical reference app for nephrology professionals, offering bulleted topics and PubMed integration on iOS and Android. **Why users hire it:** The app removes the friction of searching for evidence-based clinical synopses during patient care, replacing fragmented textbook lookups with a mobile-first reference. ## App DNA (Features & Intent) - **[Differentiator] Prime PubMed Integration:** Links clinical references directly to full-text journal articles and citations. - **[Standard] Clinical Reference Topics:** Over 150 bulleted topics covering kidney disease and electrolyte disorders. - **[Differentiator] Automatic Content Updates:** Delivers regular clinical updates throughout the subscription period. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} MGH Nephrology Guide maintains a niche presence in the Medical category, with a 4.65 rating on iOS and a 5.0 rating on Android. The reliance on a $49.99 annual subscription model necessitates high content utility to justify the cost against free medical reference alternatives. ## Monetization Strategy - **Model:** Subscription - **Tiers:** 1-year subscription at $49.99 - **Analysis:** The annual subscription model gates ongoing clinical content updates, creating a recurring revenue stream tied to professional utility. ## 🔴 User Sentiment (Medium Confidence: 1 of 1 review analyzed) {#user-sentiment} - **Overall Rating:** 4.8/5 - **Platform Split:** iOS 4.7/5 (26 ratings) | Android 5.0/5 (18 ratings) - **Overall Sentiment:** Upset - **Note:** The 4.8/5 store rating reflects cumulative history, while the Upset sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Complaints (Impact Areas) - **Information depth on specific topics feels insufficient for users seeking comprehensive educational or reference material** ## SWOT Analysis {#swot} **Core Strengths:** - Prime PubMed integration creates high professional switching costs **Growth Levers:** - Expanding topic depth for high-acuity conditions would increase renewal value ## Recent Changes (v2 → v3) {#recent-changes} The app transitioned from a free clinical reference tool to a $49.99 annual subscription model, while simultaneously facing negative user feedback regarding insufficient content depth. **Overall trend**: Mixed **Compared at**: 2026-08-01 ### High-impact changes - **[Shifted] Introduction of Annual Subscription** (pricing) - **[Declined] Negative Sentiment on Content Depth** (sentiment) ### Medium-impact changes - **[Shifted] Feature Competitive Positioning** (features) - **[Shifted] Target Audience Narrowing** (audience) ## App Momentum (Steady) {#momentum} - Shipped account management capability. - Maintains annual clinical update cadence. ## The "So What?" (Strategic Takeaway) {#so-what} MGH Nephrology Guide is a medical app. It holds a 4.8/5 rating from 44 reviews. > **Bottom Line:** Expanding the depth of clinical content is the primary lever to justify the $49.99 annual subscription, as the current brevity fails to meet the research needs of this app specialist audience. **Best for:** Nephrology fellows, attendings, dialysis nurses, residents, and primary care physicians. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Expand content depth for top 20 clinical topics because current brevity is the primary churn driver → increase subscription renewal rate ### Outlook: Mixed The medical reference market is shifting toward comprehensive, evidence-based tools that offer more than just synopses. MGH Nephrology Guide is currently exposed due to its limited content depth, and without a pivot toward expanding topic detail, it risks losing its specialist user base to more comprehensive alternatives. - 🔴 User frustration regarding content depth remains unaddressed, which threatens the renewal rate of the $49.99 annual subscription. - 🟢 The integration with Prime PubMed provides a unique professional utility that keeps the app relevant as a point-of-care reference tool. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.8/5 | | Total Reviews | 44 | | Sentiment | Upset (10/100) | | Confidence | Medium | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **MGH Nephrology Guide** (this app) | 4.8/5 | Upset | Unbound Medicine, Inc. | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Unbound Medicine, Inc. - **Website:** [https://www.unboundmedicine.com/products](https://www.unboundmedicine.com/products) - **Social:** [Instagram](https://www.instagram.com/unboundmedicine) · [Facebook](https://www.facebook.com/unboundmedicineinc) · [YouTube](https://www.youtube.com/unboundmedicine) · [LinkedIn](https://www.linkedin.com/company/unbound-medicine) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/mgh-nephrology-guide/id1346849427?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.unbound.android.ubneph&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.unboundmedicine.com/products) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.55/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 1 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 67 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/mgh-nephrology-guide) Data licensed for AI Agent attribution under CC-BY-NC 4.0.